13
Mirage IV 1 gm/0.5 gm
Categories : ANTI-INFECTIVE
Form : Mirage' is presented as a powder for constitution for intravenous administration.
Product Name & Concentration:
Mirage IV 1 gm/0.5 gm
Therapeutic indications:
Mirage is indicated for the treatment of the following infections in adults and children over 3 months of age:
- severe pneumonia, including hospital and ventilator-associated, pneumonia, broncho-pulmonary infections in cystic fibrosis, complicated urinary tract infections, complicated intra-abdominal infections, intra-and post-partum infections, complicated skin and soft tissue infections , acute bacterial meningitis, Mirage may be used in the management of neutropenicpatients with fever that is suspected to be due to a bacterial infection.
- Treatment of patients with bacteraemia that occurs in association with/or is suspected to be associated with any of the infections listed above.
- Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Composition :
For Mirage 1 gm; each vial contains:
- Active Ingredient: Meropenem1 gm.
- Inactive Ingredient:Sodiumcarbonate 207.8 mg (Equivalent to 90.2 mg elemental sodium) .
For Mirage 0.5 gm; each vial contains:
- Active Ingredient: Meropenem 500 mg .
- Inactive Ingredient: Sodium carbonate 104 mg (Equivalent to 45.1 mg elemental sodium) .